Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
AEON Mall, Mar-Nov (Cumulative 3Q) Ordinary Profit Increases by 9%, Sep-Nov Ordinary Profit Increases by 11%
8905 AEON Mall Co.,Ltd. 【J-GAAP】
Earnings ReportAEON Mall Co.,Ltd. <8905> [TSE Prime] announced its financial results after the market closed on January 9th (15:30). The consolidated ordinary profit for the cumulative third quarter of the fiscal year ending February 2025 (March to November) increased 9.3% from the same period last year, reaching 29.7 billion yen. However, the progress rate toward the full-year plan of 42 billion yen was 70.8%, almost the same as the five-year average of 70.3%.
Based on the cumulative third-quarter performance announced by the company and the unchanged full-year plan, our calculation indicates that the consolidated ordinary profit for the December to February period (4Q) is expected to grow 24.3% from the same period last year, reaching 12.2 billion yen.
In the most recent three-month period, from September to November (3Q), the consolidated ordinary profit grew 10.9% from the same period last year, reaching 8.37 billion yen. The operating profit margin improved from 9.4% in the same period last year to 10.3%.
Kabutan News
Actual Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Progress Rate vs. First Half | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Mar - Nov, 2022 | 294,600 | 32,499 | 26,624 | 10,428 | 45.8 | 73.1 | Jan 12, 2023 | J-GAAP |
Mar - Nov, 2023 | 313,859 | 34,145 | 27,222 | 14,709 | 64.6 | 73.4 | Jan 11, 2024 | J-GAAP |
Mar - Nov, 2024 | 332,729 | 38,193 | 29,742 | 12,279 | 54.0 | 70.8 | Jan 9, 2025 | J-GAAP |
YoY | +6.0% | +11.9% | +9.3% | -16.5% | -16.5% |
Current Period Guidance
Second Half Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Sep - Feb, 2023 | 212,361 | 21,983 | 17,412 | 9,894 | 43.5 | 25 | Apr 9, 2024 | J-GAAP |
Sep - Feb, 2024 Guidance | 231,269 | 28,159 | 20,632 | 7,422 | 32.6 | 25 | Oct 8, 2024 | J-GAAP |
YoY | +8.9% | +28.1% | +18.5% | -25.0% | -25.0% |
Current Period Guidance
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Adj. Dividend | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Feb, 2023 | 398,244 | 43,979 | 36,409 | 12,994 | 57.1 | 50 | Apr 11, 2023 | J-GAAP |
Feb, 2024 | 423,168 | 46,411 | 37,086 | 20,399 | 89.6 | 50 | Apr 9, 2024 | J-GAAP |
Feb, 2025 Guidance | 453,500 | 55,000 | 42,000 | 16,500 | 72.5 | 50 | Apr 9, 2024 | J-GAAP |
YoY | +7.2% | +18.5% | +13.3% | -19.1% | -19.1% |
Quarterly Results
Fiscal Year | Revenue | Operating Profit | Ordinary Profit | Net Profit | Adj. EPS | Operating Profit Margin | Announce | Accounting Standards |
---|---|---|---|---|---|---|---|---|
Sep - Nov, 2023 | 103,052 | 9,717 | 7,548 | 4,204 | 18.5 | 9.4 | Jan 11, 2024 | J-GAAP |
Dec - Feb, 2023 | 109,309 | 12,266 | 9,864 | 5,690 | 25.0 | 11.2 | Apr 9, 2024 | J-GAAP |
Mar - May, 2024 | 109,432 | 15,472 | 12,367 | 6,871 | 30.2 | 14.1 | Jul 11, 2024 | J-GAAP |
Jun - Aug, 2024 | 112,799 | 11,369 | 9,001 | 2,207 | 9.7 | 10.1 | Oct 8, 2024 | J-GAAP |
Sep - Nov, 2024 | 110,498 | 11,352 | 8,374 | 3,201 | 14.1 | 10.3 | Jan 9, 2025 | J-GAAP |
YoY | +7.2% | +16.8% | +10.9% | -23.9% | -23.8% |
Related Articles
7&i, Mar-Nov (Cumulative 3Q) Net Income Decreases by 65%, Sep-Nov Net Income Decreases by 89%
HISAMITSU PHARMA, The Current Fiscal Year Ordinary Profit Revised Upward to an Unexpected 17% Increase
Sankyo Tateyama, The Current Fiscal Year Net Income Revised Downward by 87%
Daiwa, Mar-Nov (Cumulative 3Q) Ordinary Profit Decreases by 54%, Sep-Nov Ordinary Profit Turns to Loss
CAN DO, Mar-Nov (Cumulative 3Q) Ordinary Profit Increases by 32%, Sep-Nov Ordinary Profit Increases by 2.8 times
FUJI, Mar-Nov (Cumulative 3Q) Ordinary Profit Decreases by 18%, Sep-Nov Ordinary Profit Decreases by 35%
KANSEKI , Mar-Nov (Cumulative 3Q) Ordinary Profit Turns to Profit, Sep-Nov Ordinary Profit Turns to Profit
OSAKA ORGANIC CHEMICAL, 9% Increase in Ordinary Profit for The Current Fiscal Year, Increased Previous Year's Dividend by 2 yen, This Fiscal Year to Increase Dividend by 2 yen
ARBEIT-TIMES, Mar-Nov (Cumulative 3Q) Ordinary Profit Decreases by 39%
OSG, 11% Increase in Ordinary Profit for The Current Fiscal Year